Orchestra BioMed Holdings, Inc. (OBIO)

Orchestra BioMed Holdings Revenue

Orchestra BioMed Holdings had revenue of $861.00K in the quarter ending September 30, 2025, a decrease of -12.77%. This brings the company's revenue in the last twelve months to $2.82M, up 6.46% year-over-year. In the year 2024, Orchestra BioMed Holdings had annual revenue of $2.64M, down -4.42%.

• Revenue (ttm): $2.82M
• Revenue Growth: +6.46%
• P/S Ratio: 69.37
• Revenue / Employee: $40,257
• Employees: 70
• Market Cap: 264.25M

Revenue History

Fiscal Year End	Revenue	Change	Growth
Dec 31, 2024	2.64M	-122.00K	-4.42%
Dec 31, 2023	2.76M	-773.00K	-21.88%
Dec 31, 2022	3.53M	4.32M	-
Dec 31, 2021	-782.00K	-6.49M	-
Dec 31, 2020	5.70M	-	-